Evidence map›Paper›PMID 26094232›Full record

ReviewAmerican journal of preventive medicine2015

Cost Effectiveness of a Sugar-Sweetened Beverage Excise Tax in the U.S.

Michael W Long, Steven L Gortmaker, Zachary J Ward, Stephen C Resch, Marj L Moodie, Gary Sacks, Boyd A Swinburn, Rob C Carter, Y Claire Wang

Abstract readReview
In one paragraph

Review in American journal of preventive medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Impact of sugar-sweetened beverage taxes on purchases and dietary intake: Systematic review and meta-analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Article
  15. Who pays and Who benefits? A distributional health-economic evaluation of strengthening the UK soft drinks industry levy.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael W LongDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Electronic address: michael.long@mail.harvard.edu.
Steven L GortmakerDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Zachary J WardCenter for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Stephen C ReschCenter for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Marj L MoodieDeakin Health Economics, Deakin University, Melbourne, Victoria, Australia.
Gary SacksWHO Collaborating Centre for Obesity Prevention, Deakin University, Melbourne, Victoria, Australia.
Boyd A SwinburnWHO Collaborating Centre for Obesity Prevention, Deakin University, Melbourne, Victoria, Australia; Section of Epidemiology and Biostatistics, the School of Population Health, University of Auckland, New Zealand.
Rob C CarterDeakin Health Economics, Deakin University, Melbourne, Victoria, Australia.
Y Claire WangDepartment of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York.

Funding

HARVARD PREVENTION RESEARCH CENTER ON NUTRITION AND PHYSICAL ACTIVITY-CATEGORY 1U48DP001946 · DP · HARVARD SCHOOL OF PUBLIC HEALTH · PI GORTMAKER, STEVEN L · 2009 to 2013
$7.5M
NCCDPHP CDC HHS U48 DP001946NCCDPHP CDC HHS U48/DP001946
6 · The paper itself

Abstract

introductionReducing sugar-sweetened beverage consumption through taxation is a promising public health response to the obesity epidemic in the U.S. This study quantifies the expected health and economic benefits of a national sugar-sweetened beverage excise tax of $0.01/ounce over 10 years.

methodsA cohort model was used to simulate the impact of the tax on BMI. Assuming ongoing implementation and effect maintenance, quality-adjusted life-years gained and disability-adjusted life-years and healthcare costs averted were estimated over the 2015-2025 period for the 2015 U.S. POPULATION: Costs and health gains were discounted at 3% annually. Data were analyzed in 2014.

resultsImplementing the tax nationally would cost $51 million in the first year. The tax would reduce sugar-sweetened beverage consumption by 20% and mean BMI by 0.16 (95% uncertainty interval [UI]=0.06, 0.37) units among youth and 0.08 (95% UI=0.03, 0.20) units among adults in the second year for a cost of $3.16 (95% UI=$1.24, $8.14) per BMI unit reduced. From 2015 to 2025, the policy would avert 101,000 disability-adjusted life-years (95% UI=34,800, 249,000); gain 871,000 quality-adjusted life-years (95% UI=342,000, 2,030,000); and result in $23.6 billion (95% UI=$9.33 billion, $54.9 billion) in healthcare cost savings. The tax would generate $12.5 billion in annual revenue (95% UI=$8.92, billion, $14.1 billion).

conclusionsThe proposed tax could substantially reduce BMI and healthcare expenditures and increase healthy life expectancy. Concerns regarding the potentially regressive tax may be addressed by reduced obesity disparities and progressive earmarking of tax revenue for health promotion.

Indexed as

BeveragesCohort StudiesCost-Benefit AnalysisHealth Care CostsHumansObesityQuality-Adjusted Life YearsSweetening AgentsTaxesUnited StatesSweetening Agents

Identifiers

PMID26094232
PMCPMC8969866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.